Back to company

EJP PHARMACEUTICAL ApS: Financial statements 2024

CVR: 87923614

EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -32,946 and a net result of DKK 414,071 compared with DKK 453,582 the year before. Equity amounted to DKK 4,428,783. The solvency ratio was 98.1%. The company had 1 employee in the financial year.

Gross Profit
-32,946 kr.
Profit/Loss
414,071 kr.
Equity
4,428,783 kr.
Total Assets
4,513,036 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--33 t.414 t.4.4 mio.1
2023--34 t.454 t.4.1 mio.1
2022--49 t.-478 t.6.7 mio.1
2021--40 t.443 t.7.3 mio.1
2020--75 t.-140 t.6.9 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EJP PHARMACEUTICAL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

EJP PHARMACEUTICAL ApS: The 2023 annual report is outMay 7, 2024

EJP PHARMACEUTICAL ApS has published its annual report for 2023. Gross profit came to DKK -34,271, and the net result was DKK 453,582.

About EJP PHARMACEUTICAL ApS

EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.